Sotyktu Gains Ground in Psoriatic Arthritis, but Rheumatologists Remain Selective as Its Role in the Treatment Algorithm Takes Shape, According to Spherix Global Insights
New research finds growing prescriber adoption and enthusiasm for TYK2 differentiation, while limited experience, access friction, and questions around joint efficacy temper early launch momentum. New research finds growing prescriber adoption and enthusiasm for TYK2 differentiation, while limited experience, access fr…
Solo un extracto — este editor licencia su texto. Lea el comunicado completo en la fuente.
Cancele cuando quiera · 99 CA$/mes


